Published in J Natl Cancer Inst on July 18, 2001
Screening for breast cancer. JAMA (2005) 4.56
Choice of management of southern Chinese BRCA mutation carriers. World J Surg (2010) 1.50
Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. Br J Cancer (2004) 1.43
Power spectral analysis of mammographic parenchymal patterns for breast cancer risk assessment. J Digit Imaging (2008) 1.41
Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance. Cancer (2011) 1.41
Breast cancer imaging: a perspective for the next decade. Med Phys (2008) 1.29
Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort. Br J Cancer (2002) 1.11
Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers. Radiology (2010) 1.09
Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection? Eur Radiol (2006) 1.07
Evaluation of novel genetic algorithm generated schemes for positron emission tomography (PET)/magnetic resonance imaging (MRI) image fusion. J Digit Imaging (2011) 1.05
Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience. BMC Cancer (2006) 1.01
New technologies in screening for breast cancer: a systematic review of their accuracy. Br J Cancer (2004) 1.01
Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting. Fam Cancer (2009) 0.97
Integration of microwave tomography with magnetic resonance for improved breast imaging. Med Phys (2013) 0.95
The significance of circumscribed malignant mammographic masses in the surveillance of BRCA 1/2 gene mutation carriers. Eur Radiol (2004) 0.93
MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC). Fam Cancer (2001) 0.93
Impact of screening for breast cancer in high-risk women on health-related quality of life. Br J Cancer (2004) 0.92
Sensitivity of MRI-guided near-infrared spectroscopy clinical breast exam data and its impact on diagnostic performance. Biomed Opt Express (2014) 0.89
Expanding the indications for MRI in the diagnosis and treatment of breast cancer: what is best practice? J Med Radiat Sci (2015) 0.89
Pearls and pitfalls in breast MRI. Br J Radiol (2011) 0.87
Diagnostic accuracy of fused positron emission tomography/magnetic resonance mammography: initial results. Br J Radiol (2010) 0.87
Multimodality breast cancer screening in women with a familial or genetic predisposition. Curr Oncol (2010) 0.86
Current applications and future direction of MR mammography. Br J Cancer (2003) 0.84
Usefulness of a small-field digital mammographic imaging system using parabolic polycapillary optics as a diagnostic imaging tool: a preliminary study. Korean J Radiol (2009) 0.84
Molecular Imaging in Breast Cancer - Potential Future Aspects. Breast Care (Basel) (2011) 0.83
Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage. Health Expect (2005) 0.82
Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study. Br J Cancer (2006) 0.80
Prospective screening study of 0.5 Tesla dedicated magnetic resonance imaging for the detection of breast cancer in young, high-risk women. BMC Womens Health (2006) 0.80
Screening women at increased risk with MRI. Cancer Imaging (2005) 0.79
Re: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst (2001) 0.79
Assessing and managing breast cancer risk: clinical tools for advising patients. MedGenMed (2004) 0.78
Breast cancer prevention in women with a BRCA1 or BRCA2 mutation. Open Med (2007) 0.77
Positive predictive value of additional synchronous breast lesions in whole-breast ultrasonography at the diagnosis of breast cancer: clinical and imaging factors. Ultrasonography (2014) 0.75
MRI screening for breast cancer in women at high risk; is the Australian breast MRI screening access program addressing the needs of women at high risk of breast cancer? J Med Radiat Sci (2015) 0.75
Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers. Fam Cancer (2013) 0.75
3D microwave tomography of the breast using prior anatomical information. Med Phys (2016) 0.75
PET/MRI in Oncological Imaging: State of the Art. Diagnostics (Basel) (2015) 0.75
Comment on screening by MRI mentioned in the reviews by narod and møller. Hered Cancer Clin Pract (2004) 0.75
Should we use MRI to screen women at high-risk of breast cancer? Cancer Imaging (2005) 0.75
Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Lancet (1984) 10.22
Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer (1985) 3.60
Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet (1994) 3.45
The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers. Cancer (1993) 2.88
Testicular carcinoma: postmortem diagnosis after a car accident. Lancet (2002) 2.79
[The treatment of ductal carcinoma in situ (DCIS) of the breast]. Ned Tijdschr Geneeskd (2003) 2.67
Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol (2008) 2.52
New FIGO staging system of vulvar cancer indeed provides a better reflection of prognosis. Gynecol Oncol (2010) 2.27
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol (2008) 2.19
The contribution of routine follow-up mammography to an early detection of asynchronous contralateral breast cancer. Cancer (1991) 2.10
Breast cancer size estimation with MRI in BRCA mutation carriers and other high risk patients. Eur J Radiol (2013) 2.06
Precision and accuracy in measuring absence from work as a basis for calculating productivity costs in The Netherlands. Soc Sci Med (2000) 2.01
Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer (1991) 1.97
Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet (1990) 1.96
The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer (1989) 1.94
Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology (1995) 1.93
Nationwide breast cancer screening programme fully implemented in The Netherlands. Breast (2001) 1.88
High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer. J Clin Oncol (2003) 1.86
Age-dependent growth rate of primary breast cancer. Cancer (1993) 1.80
Value of breast imaging in women with painful breasts: observational follow up study. BMJ (1998) 1.78
Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst (2010) 1.78
Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg (1999) 1.76
Mammographic screening and breast cancer mortality: age-specific effects in Nijmegen Project, 1975-82. Lancet (1985) 1.76
Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion (1997) 1.75
The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol (1990) 1.71
Endocrine treatment options for advanced breast cancer--the role of fulvestrant. Eur J Cancer (2005) 1.65
Unusual retinal pigment epitheliopathy and choroidopathy in carcinomatosis: a rare case of cancer-associated retinopathy. Graefes Arch Clin Exp Ophthalmol (1997) 1.64
Colonic duplications: clinical presentation and radiologic features of five cases. Eur J Radiol (2006) 1.62
Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol (2002) 1.52
High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. J Clin Endocrinol Metab (2001) 1.52
Recurrent esophageal fibrovascular polyps: case history and review of the literature. Dig Dis Sci (2002) 1.51
So-called interval cancers of the breast. Pathologic and radiologic analysis of sixty-four cases. Cancer (1982) 1.50
Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol (1994) 1.48
Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am J Roentgenol (1996) 1.46
Evaluation of chemotherapy with magnetic resonance imaging in patients with regionally metastatic or unresectable bladder cancer. Eur Urol (2006) 1.45
Small-bowel perforation complicating the open treatment of generalized peritonitis. Arch Surg (1989) 1.42
Surgical morbidity and clinical outcomes in ovarian cancer - the role of obesity. BJOG (2016) 1.41
Do non-specific minimal signs in a biennial mammographic breast cancer screening programme need further diagnostic assessment? Br J Radiol (1997) 1.40
[Palliation in patients with metastatic breast cancer often better with antitumour treatment than with only symptomatic treatment]. Ned Tijdschr Geneeskd (2007) 1.40
[Feasibility of MRI imaging in patients with breast cancer]. Ned Tijdschr Geneeskd (2005) 1.39
Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: assessment of early indicators of screening effectiveness. J Natl Cancer Inst (1994) 1.39
[Tumor markers in screening, diagnosis and treatment of patients with breast carcinoma]. Ned Tijdschr Geneeskd (1993) 1.38
Malignant peritoneal mesothelioma in a 76-year-old woman with a history of asbestos fiber ingestion. Int J Gynecol Cancer (2004) 1.38
Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.37
Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res (1997) 1.35
Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer. Ann Oncol (2003) 1.35
Nation-wide breast cancer screening in The Netherlands: support for breast-cancer mortality reduction. National Evaluation Team for Breast Cancer Screening (NETB). Int J Cancer (1995) 1.34
Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology (1997) 1.32
MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology (1994) 1.32
Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening. Int J Cancer (1998) 1.31
Mammographically occult breast cancer. A pathologic and radiologic study. Cancer (1983) 1.30
Evaluation of overdiagnosis of breast cancer in screening with mammography: results of the Nijmegen programme. Int J Epidemiol (1989) 1.25
Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma. Cancer Res (1999) 1.24
Screening for breast cancer in Nijmegen. Report of 6 screening rounds, 1975-1986. Int J Cancer (1989) 1.23
Couples dealing with cancer: role and gender differences regarding psychological distress and quality of life. Psychooncology (2000) 1.22
Mammographic breast density and risk of breast cancer: masking bias or causality? Eur J Epidemiol (1998) 1.21
In vivo destruction of tumor tissue by cryoablation can induce inhibition of secondary tumor growth: an experimental study. Cryobiology (2001) 1.21
Typhoid fever in Ujung Pandang, Indonesia--high-risk groups and high-risk behaviours. Trop Med Int Health (1997) 1.19
Interval cancers in the Dutch breast cancer screening programme. Br J Cancer (1999) 1.18
Pulmonary artery root dilatation in Marfan syndrome: quantitative assessment of an unknown criterion. Heart (2002) 1.18
Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol (1994) 1.18
Marital satisfaction in patients with cancer: does support from intimate partners benefit those who need it the most? Health Psychol (2000) 1.16
Changes in mammographic breast density and concomitant changes in breast cancer risk. Eur J Cancer Prev (1999) 1.16
The cost-effectiveness of breast cancer screening. Int J Cancer (1989) 1.16
Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging. Eur Radiol (2009) 1.14
Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy. Cancer Treat Rev (2009) 1.14
In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. Anticancer Res (1997) 1.14
Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality. Int J Cancer (1996) 1.13
Accurate estimation of pharmacokinetic contrast-enhanced dynamic MRI parameters of the prostate. J Magn Reson Imaging (2001) 1.12
Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. AJR Am J Roentgenol (1996) 1.12
Pain experienced by women attending breast cancer screening. Breast Cancer Res Treat (2000) 1.10
Early detection of breast and ovarian cancer in families with BRCA mutations. Eur J Cancer (2005) 1.10
ABC of sleep disorders. Sleep disorders in children. BMJ (1993) 1.08
Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer. J Magn Reson Imaging (1999) 1.08
Groningen Active Living Model (GALM): stimulating physical activity in sedentary older adults. Prev Med (1999) 1.07
The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat (2010) 1.07
[Observed effects of the mass screening program for breast cancer in Nijmegen in 1975-1986]. Ned Tijdschr Geneeskd (1990) 1.07
False-negative MR imaging of malignant breast tumors. Eur Radiol (1997) 1.07
[The relationship between serum concentration of the prostate-specific antigen and the skeletal and CT-scan in the staging of primary prostate cancer]. Ned Tijdschr Geneeskd (1998) 1.07
Quality of life as an outcome measure in surgical oncology. Br J Surg (2001) 1.07
Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92. J Epidemiol Community Health (1996) 1.07
Incidence and clinical course of de-novo malignancies in renal allograft recipients. Eur J Surg Oncol (2001) 1.07
US correlation for MRI-detected breast lesions in women with familial risk of breast cancer. Clin Radiol (2005) 1.06
Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands. J Epidemiol Community Health (1998) 1.06
One-view versus two-view mammography in baseline screening for breast cancer: a review. Br J Radiol (1992) 1.06
The effect of antineoplastic agents on the healing of small intestinal anastomoses in the rat. Cancer (1986) 1.05
Meniscal cysts: detection with high-resolution sonography. AJR Am J Roentgenol (1998) 1.05